Ligand validation:6PP0

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PP0_BTB_C_505	59%	36%	0.148	0.929	0.93	1.55	1	2	5	0	100%	1
6PP0_BTB_C_504	39%	55%	0.221	0.929	0.46	1.27	-	1	6	0	100%	1
6PP0_BTB_B_505	35%	66%	0.209	0.896	0.43	0.86	-	-	6	0	100%	1
6PP0_BTB_A_505	34%	69%	0.167	0.848	0.49	0.7	-	-	1	0	100%	1
6PP0_BTB_A_504	34%	55%	0.215	0.897	0.5	1.2	-	1	0	0	100%	1
6PP0_BTB_B_504	31%	71%	0.163	0.829	0.41	0.7	-	-	6	0	100%	1
6PP0_BTB_D_505	25%	64%	0.212	0.847	0.48	0.88	-	-	7	0	100%	1
6PP0_BTB_D_504	22%	75%	0.192	0.808	0.4	0.56	-	-	1	0	100%	1
6PP0_BTB_C_506	7%	83%	0.226	0.68	0.47	0.32	-	-	5	0	100%	1
6PP0_BTB_B_506	3%	77%	0.298	0.64	0.38	0.54	-	-	4	0	100%	1
6PP0_BTB_A_506	2%	84%	0.322	0.571	0.43	0.34	-	-	7	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.